(Q53245476)

12 May 2018

title

Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study. (English)

1 reference

12 May 2018

1 reference

Lyketsos CG

1

1 reference

12 May 2018

Sheppard JM

2

1 reference

12 May 2018

Steinberg M

3

1 reference

12 May 2018

Tschanz JA

4

1 reference

12 May 2018

Norton MC

5

1 reference

12 May 2018

Steffens DC

6

1 reference

12 May 2018

Breitner JC

7

1 reference

12 May 2018

language of work or name

English

0 references

publication date

1 November 2001

1 reference

12 May 2018

International Journal of Geriatric Psychiatry

published in

1 reference

12 May 2018

volume

16

1 reference

12 May 2018

issue

11

1 reference

12 May 2018

page(s)

1043-1053

1 reference

12 May 2018

APOE-epsilon4 count predicts age when prevalence of AD increases, then declines: the Cache County Study.

cites work

1 reference

Psychiatric phenomena in Alzheimer's disease. IV: Disorders of behaviour

21 January 2018

1 reference

The subtyping of schizophrenia in men and women: a latent class analysis

21 January 2018

1 reference

The course of psychopathologic features in mild to moderate Alzheimer disease.

21 January 2018

1 reference

DSM-III major depressive disorder in the community. A latent class analysis of data from the NIMH epidemiologic catchment area programme

21 January 2018

1 reference

Exploratory latent structure analysis using both identifiable and unidentifiable models

21 January 2018

1 reference

Psychosis of Alzheimer's disease and related dementias. Diagnostic criteria for a distinct syndrome.

21 January 2018

1 reference

Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: a randomized, double-blind trial. Risperidone Study Group

21 January 2018

1 reference

Wandering behaviour in community-residing persons with dementia.

21 January 2018

1 reference

Physical aggression in dementia patients and its relationship to depression.

21 January 2018

1 reference

Randomized, placebo-controlled, double-blind clinical trial of sertraline in the treatment of depression complicating Alzheimer's disease: initial results from the Depression in Alzheimer's Disease study

21 January 2018

1 reference

Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging

21 January 2018

1 reference

The spectrum of behavioral changes in Alzheimer's disease.

21 January 2018

1 reference

The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study.

21 January 2018

1 reference

Serotonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms

21 January 2018

1 reference

Delusions in Alzheimer's disease: a review.

21 January 2018

1 reference

Emergence of psychosis and depression in the longitudinal evaluation of Alzheimer's disease.

21 January 2018

1 reference

Reliability of the family history method in genetic studies of Alzheimer's disease and related dementias.

21 January 2018

1 reference

Efficacy and tolerability of carbamazepine for agitation and aggression in dementia

21 January 2018

1 reference

The Behavior Rating Scale for Dementia of the Consortium to Establish a Registry for Alzheimer's Disease. The Behavioral Pathology Committee of the Consortium to Establish a Registry for Alzheimer's Disease.

21 January 2018

1 reference

A 5-month, randomized, placebo-controlled trial of galantamine in AD. The Galantamine USA-10 Study Group.

21 January 2018

1 reference

Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease

21 January 2018

1 reference

Evaluating diagnostic criteria: a latent class paradigm.

21 January 2018

1 reference

Neurochemical Correlates of Major Depression in Primary Dementia

21 January 2018

1 reference

Neuropathologic and neurochemical correlates of psychosis in primary dementia.

21 January 2018

1 reference

The neuropathology of aminergic nuclei in Alzheimer's disease.

21 January 2018

1 reference

Behavioral Syndromes in Alzheimer’s Disease: Description and Correlates

21 January 2018

1 reference

Psychiatric phenomena in Alzheimer's disease. I: Disorders of thought content

21 January 2018

1 reference

7 January 2021

Psychiatric phenomena in Alzheimer's disease. II: Disorders of perception

1 reference

7 January 2021

Psychiatric phenomena in Alzheimer's disease. III: Disorders of mood

1 reference

7 January 2021

The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia

1 reference

7 January 2021

Psychotic symptoms and the longitudinal course of senile dementia of the Alzheimer type

1 reference

7 January 2021

A short form of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): development and cross-validation.

1 reference

7 January 2021

Double-blind trial of imipramine in Alzheimer's disease patients with and without depression

1 reference

7 January 2021

A SPECT study of delusions in Alzheimer's disease

1 reference

7 January 2021

Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities: a double-blind, randomized, placebo-controlled trial. The HGEU Study Group

1 reference

7 January 2021

Identifiers

DOI

10.1002/GPS.448

1 reference

12 May 2018

PubMed ID

11746650

1 reference

12 May 2018